Trials / Sponsors / OncoResponse, Inc.
OncoResponse, Inc.
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents Cancer, Tumor, Solid, Malignant Neoplasm | Phase 1 / Phase 2 | 2023-10-24 |
| Unknown | A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Cancer, Tumor, Solid, Malignant Neoplasm | Phase 1 / Phase 2 | 2021-09-09 |